VMS BioMarketing has added Jennifer Wilson as chief financial officer. She previously served as vice president leading business development at TherapeuticsMD. Wilson started her career in investment banking, working in the Bank of America Merrill Lynch healthcare group. Innovation across life sciences and healthcare services allowed her to work on transformational strategic transactions for companies such as Valeant Pharmaceuticals, Cardinal Health, and Iasis Healthcare.
From investment banking she then moved to Anthem’s Corporate Development team where she led execution on hallmark transactions such as Amerigroup, Cigna, 1-800 Contacts and American Well.